[Skip to Content]
[Skip to Content Landing]
Views 1,163
Citations 0
Global Health
June 18, 2019

Vaccine Reduces Pneumonia in Kenya

JAMA. 2019;321(23):2273. doi:10.1001/jama.2019.7978

Introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) resulted in sharply reduced pneumonia cases in Kenya, according to a report from an international team of researchers.

In 2011, Kenya was the first African country to add PCV10 to its national childhood immunization schedule. The vaccine protects against 10 common strains of Streptococcus pneumoniae. The schedule called for a 3-dose series administered to infants at 6, 10, and 14 weeks of age, with a catch-up campaign for children younger than 5 years.

×